Legislation & Regulation

September 2023 Legislative & Regulatory Briefing: Access to PDTs Act of 2023 Discussed in a House Energy & Committee Hearing; AMCP Comments on Coverage with Evidence Development Proposed Guidance; Adam Colborn Discusses AMCP’s Legislative & Regulatory Priorities for 2023; Now Available: AMCP’s Inflation Reduction Act Resource Center; 2023 Call for AMCP Committee Applications Now Open.

July 2023 Legislative & Regulatory Briefing: Tell Congress to Pass the MVP Act of 2023; AMCP Gathers PDT Manufacturers for Product Demonstrations on Capitol Hill; AMCP’s Adam Colborn Discusses Biosimilar Interchangeability with AJMC; Register for the Inflation Reduction Act Pre-Conference Program at AMCP Nexus 2023; Catch Up on the Latest Regulatory NewsBREAKs.

August 2023 Legislative & Regulatory Briefing: The Equitable Community Access to Pharmacist Services Act of 2023 is Introduced in the Senate; AMCP Hosts its First Virtual IRA Workshop; AMCP’s Adam Colborn Discusses PBM, Medicaid Best Price, and PDT Legislation; Register for the IRA Pre-Conference Program at Nexus 2023; Is Now the Time for Prescription Digital Therapeutics?

June 2023 Legislative & Regulatory Briefing: AMCP Advocates Visit Congress for Legislative Days 2023; AMCP Submits Comments on Manufacturer Discount Program Draft Guidance; AMCP to Showcase Prescription Digital Therapeutics (PDTs) on Capitol Hill; AMCP Comments on Proposed Rules Regarding Privacy and Health Data; AMCP, Health Care Organizations Thank the Biden Administration for Relaunching the Cancer Moonshot.